Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryosurgery and NK Immunotherapy for Recurrent Laryngeal Cancer
NCT02849314Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
Phase 2 trial of Natural Killer Cells in laryngeal cancer (2 arms), sponsored by Fuda Cancer Hospital. Primary endpoint: Relief degree of tumors at 3 months. Started Jul 2016; status: completed.
02
Drugs
Natural Killer Cells
03
Conditions
laryngeal cancer
Beyond the preview
Go deeper on NCT02849314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849314.